Search research articles
Contact Us
Filters
Showing results (131-140 of 134) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 134 results.
Journal for Immunotherapy of Cancer
|
March 3, 2026
Effects of oncolytic immunotherapy with RP1 (vusolimogene oderparepvec) on immune cells mediate responsiveness to anti-PD-1 via STING-mediated interferon signaling
Victoria Roulstone, Joan Kyula, Elizabeth Appleton, et al.
Nature Communications
|
March 6, 2026
Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy
Winnie Fernando, Jarama Clucas, Alberto Rizzo, et al.
Oncoimmunology
|
June 26, 2023
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6<sup>th</sup> annual ImmunoRad conference
Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, et al.
Nature Communications
|
April 8, 2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy
Marie-Eve Wedge, Victoria A Jennings, Mathieu J F Crupi, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 134) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 134 results.
Journal for Immunotherapy of Cancer
|
March 3, 2026
Effects of oncolytic immunotherapy with RP1 (vusolimogene oderparepvec) on immune cells mediate responsiveness to anti-PD-1 via STING-mediated interferon signaling
Victoria Roulstone, Joan Kyula, Elizabeth Appleton, et al.
Nature Communications
|
March 6, 2026
Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy
Winnie Fernando, Jarama Clucas, Alberto Rizzo, et al.
Oncoimmunology
|
June 26, 2023
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6<sup>th</sup> annual ImmunoRad conference
Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, et al.
Nature Communications
|
April 8, 2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy
Marie-Eve Wedge, Victoria A Jennings, Mathieu J F Crupi, et al.
Page
of 14